High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

The aim of this work was to examine the expression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in non-small cell lung cancer (NSCLC) and analyze its correlation with clinical outcomes. CIP2A protein levels were detected by immunohistochemistry (IHC). One hundred and eighty-four of 209 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Geqi, Xu, Jianyu, Xu, Xiangying, Li, Bin, Lu, Shan, Nanding, Abiyasi, Hu, Songliu, Liu, Shilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731340/
https://www.ncbi.nlm.nih.gov/pubmed/29276394
http://dx.doi.org/10.2147/OTT.S148250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731340/
https://www.ncbi.nlm.nih.gov/pubmed/29276394
http://dx.doi.org/10.2147/OTT.S148250

Ejemplares similares